Connect with us

The Conversation

Biden is getting prostate cancer treatment, but that’s not the best choice for all men − a cancer researcher describes how she helped her father decide

Published

on

theconversation.com – Luisel Ricks-Santi, Senior Associate Vice President Community Health, Education and Training, Old Dominion University; Associate Professor of Pharmacy, University of Florida – 2025-05-20 13:28:00


A cancer researcher reflects on his father’s prostate cancer diagnosis, sharing their journey through decision-making and treatment options. After an initial benign prostate hyperplasia (BPH) diagnosis, his father’s PSA levels rose, leading to an intermediate-risk prostate cancer diagnosis. Despite treatment recommendations, the researcher guided his father through active surveillance, a strategy for early-stage cancer. He emphasizes the risks of overdiagnosis and overtreatment, advocating for personalized decisions based on individual cancer progression. With genetic tests indicating a low five-year mortality risk, his father opted for continued monitoring, understanding that the best approach varies for each patient.

Joe Biden’s Cancer Moonshot initiative had funded hundreds of cancer research projects across the country.
AP Photo/Gerald Herbert

Luisel Ricks-Santi, University of Florida

“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.”

As a cancer researcher who knows very well about the high incidence and decreased survival rates of prostate cancer in the Caribbean, I anguished over these words. Even though I study cancer in my day job, I struggled to take in this news. At the time, all I could muster in response was, “What did the doctor say?”

“The urologist wants me to see the radiation oncologist to discuss ‘semillas’ (seeds),” he said. “They are recommending treatment.” Many men, including former President Joe Biden, whose case is advanced, do choose with their doctors to treat prostate cancer.

However, I understood from my work that not undergoing treatment was also an option. In some cases, that is the better choice.

So I took it upon myself to educate my father on his disease and assist him with the life-changing decisions he would need to make. Our journey can give you a preview of what a cancer diagnosis can be like.

Prostate cancer diagnosis

Prostate cancer was not a new topic for my father and me. His battle with his prostate health started over 10 years ago with an initial diagnosis of benign prostate hyperplasia, or BPH.

The prostate gets bigger with age for a number of reasons, including changing hormone levels, infection or inflammation. Two of the most frequent symptoms of BPH are difficulty urinating and a sudden, urgent need to urinate, both of which my father experienced.

Although research suggests that the factors that contribute to BPH similarly contribute to prostate cancer, there is no evidence that an enlarged prostate will necessarily develop into cancer.

Prostate cancer diagnoses have risen in the U.S. in recent years.

Upon my father’s initial BPH diagnosis, I asked about his PSA levels, the amount of prostate-specific antigens in his blood. PSA is a protein that both normal and cancerous prostate cells produce, and elevated amounts are considered red flags for prostate cancer. When combined with a digital rectal exam, a PSA test can allow doctors to more accurately predict a person’s risk of having prostate cancer.

My father said his PSA levels were elevated but that the doctors would begin active surveillance, what he called “watchful waiting,” and monitor his PSA every six months to see if it rose.

After several years of monitoring his PSA, doctors found my father’s PSA level had doubled. He then got a biopsy that indicated he had intermediate-risk prostate cancer.

Cancer risk categorization

After his diagnosis, my father was faced with the decision of how to proceed with treatment. I explained that categorizing how aggressive the cancer is and how far it has spread can help determine the best course of treatment.

Prostate cancer can be grouped into four stages. Stages 1 and 2, when the tumor is still confined to the prostate, are considered early-stage or intermediate risk. Stages 3 and 4, when the tumor has spread beyond the borders of the prostate, are considered more advanced and high risk.

Some patients with early-stage or intermediate-risk prostate cancer undergo additional treatment, including surgery, radiation or radioactive seed implants called brachytherapy. Patients with late-stage prostate cancer typically undergo hormone therapy along with surgery or radiation, or chemotherapy with or without radiation.

Although I was not surprised by my father’s diagnosis, given his advanced age and his battle with prostate disease over the past decade, I still struggled emotionally. I struggled with our conversations about what “curing” his cancer meant and how to explain his treatment options to him. I wanted to ensure he would have the best outcome and could still live his best life.

Our initial inclination was to undergo active surveillance. That meant we would monitor his PSA every six months instead of immediately starting treatment. That is appropriate for patients with early-stage and less aggressive tumors.

Prostate cancer screening problems

My father was leaning on me to help him decide how to proceed. I felt overwhelming anxiety because I did not want to fail him or my family. Even with all my expertise studying cancer genetics and working with cancer patients, I couldn’t help second-guessing our decisions, and I sometimes questioned our decision not to immediately treat his cancer.

Some people diagnosed with prostate cancer don’t immediately start treatment, because many of the tumors found through PSA testing grow so slowly that they are unlikely to be life-threatening. Detecting these slow-growing tumors is considered overdiagnosis, because the cancer ultimately will not harm the patient during their lifetime. Nearly half of all patients with prostate cancer are overdiagnosed, often leading to overtreatment.

Research suggests that many prostate cancer patients undergo unnecessarily aggressive treatments, which are often associated with significant harms, like urinary and bowel incontinence, sexual impotence and, in some cases, death. Several studies in the U.S. have shown that patients with early-stage prostate cancer generally have a good prognosis, and the cancer rarely progresses further. With careful observation, most will never need treatment and can be spared the burdens of unnecessary therapy until there are clear signs of progression.

The U.S. Preventive Services Task Force recommended personalized PSA-based screening in 2018 to avoid overdiagnosis and overtreatment.

Overdiagnosis and overtreatment of prostate cancer led the U.S. Preventive Services Task Force to recommend against PSA-based screening in 2012, with caveats for high-risk groups including African American men and those with a family history of prostate cancer. The recommendation was updated in 2018 to make screening a personal choice after discussion with a clinician.

Those recommendations have resulted in reduced screening and increased prostate cancer diagnoses. Given that Black men are more likely to see the cancer progress to aggressive forms of the disease after initial diagnosis, this may worsen existing health disparities.

Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the meantime, educating patients can help them decide if screening is appropriate for them. For underserved and marginalized communities, community outreach can help improve health literacy and enhance awareness and screening.

When I looked through my father’s stack of medical records, I found a beacon of light that eased my apprehension. His doctor had ordered a genetic test that estimates how aggressive a tumor may be by measuring the activity of specific genes in cancer cells. An increase in gene activity linked to cancer would indicate that it is likely to grow fast and spread.

The test predicted that my father’s risk of dying from the disease in the next five years was less than 5%. Based on these results, we both understood that he had adequate time to make a decision and seek additional guidance.

My father ultimately decided to continue active surveillance and forgo immediate treatment.

Person holding hand of patient lying in hospital bed
Because of disparities in access to screening and treatment, African American men are more likely to be diagnosed with advanced prostate cancer.
FG Trade/E+ via Getty Images

Surviving prostate cancer

I still worry about my father’s diagnosis, because his cancer is at risk for progression. So every six months, I inquire about his PSA levels. His doctors are monitoring his PSA levels as part of his survivorship plan, which is a record of information about his cancer diagnosis, treatment history and potential follow-up tests.

My father’s decision to undergo active surveillance was controversial among our friends and family. Many were under the impression that prostate cancer required immediate treatment. Several shared successful treatment stories, sometimes followed by stories of adverse treatment-related side effects.

To date, my father believes that active surveillance was the best decision for him and understands that this may not be the same for someone else. Talk to your doctor to see what the best options are for you or your loved ones.

This is an updated version of an article originally published on Aug. 8, 2023.The Conversation

Luisel Ricks-Santi, Senior Associate Vice President Community Health, Education and Training, Old Dominion University; Associate Professor of Pharmacy, University of Florida

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Biden is getting prostate cancer treatment, but that’s not the best choice for all men − a cancer researcher describes how she helped her father decide appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This article primarily focuses on the personal experience of a cancer researcher helping her father navigate a prostate cancer diagnosis and treatment options. It discusses medical procedures, research, and personal decisions without presenting a clear ideological stance or political angle. The author presents both sides of treatment and emphasizes the importance of patient choice, indicating an approach that is informative and balanced. Additionally, the inclusion of health disparities, such as the disproportionate impact of prostate cancer on African American men, does not lean politically but highlights ongoing public health issues. The tone remains neutral, aiming to educate rather than advocate for a particular political viewpoint.

The Conversation

I’m a physician who has looked at hundreds of studies of vaccine safety, and here’s some of what RFK Jr. gets wrong

Published

on

theconversation.com – Jake Scott, Clinical Associate Professor of Infectious Diseases, Stanford University – 2025-06-26 07:31:00


Robert F. Kennedy Jr., since becoming Health and Human Services secretary, has made many false claims about vaccines, including exaggerating mandatory shots for children and alleging conflicts of interest among vaccine advisers. In reality, children receive about 30-32 required vaccine doses protecting against 10-12 diseases, far fewer than his claimed 92. Modern vaccines contain far fewer antigens and improved adjuvants, reducing immune burden. Controlled trials, including placebo comparisons, have tested all routine vaccines extensively. U.S. monitoring systems track vaccine safety continuously. Allegations of widespread conflicts of interest among advisers are unfounded, and vaccines have significantly reduced childhood illnesses and deaths.

Public health experts worry that factually inaccurate statements by Robert F. Kennedy Jr. threaten the public’s confidence in vaccines.
Andrew HarnikGetty Images

Jake Scott, Stanford University

In the four months since he began serving as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. has made many public statements about vaccines that have cast doubt on their safety and on the objectivity of long-standing processes established to evaluate them.

Many of these statements are factually incorrect. For example, in a newscast aired on June 12, 2025, Kennedy told Fox News viewers that 97% of federal vaccine advisers are on the take. In the same interview, he also claimed that children receive 92 mandatory shots. He has also widely claimed that only COVID-19 vaccines, not other vaccines in use by both children and adults, were ever tested against placebos and that “nobody has any idea” how safe routine immunizations are.

As an infectious disease physician who curates an open database of hundreds of controlled vaccine trials involving over 6 million participants, I am intimately familiar with the decades of research on vaccine safety. I believe it is important to correct the record – especially because these statements come from the official who now oversees the agencies charged with protecting Americans’ health.

Do children really receive 92 mandatory shots?

In 1986, the childhood vaccine schedule contained about 11 doses protecting against seven diseases. Today, it includes roughly 50 injections covering 16 diseases. State school entry laws typically require 30 to 32 shots across 10 to 12 diseases. No state mandates COVID-19 vaccination. Where Kennedy’s “92 mandatory shots” figure comes from is unclear, but the actual number is significantly lower.

From a safety standpoint, the more important question is whether today’s schedule with additional vaccines might be too taxing for children’s immune systems. It isn’t, because as vaccine technology improved over the past several decades, the number of antigens in each vaccine dose is much lower than before.

Antigens are the molecules in vaccines that trigger a response from the immune system, training it to identify the specific pathogen. Some vaccines contain a minute amount of aluminum salt that serves as an adjuvant – a helper ingredient that improves the quality and staying power of the immune response, so each dose can protect with less antigen.

Those 11 doses in 1986 delivered more than 3,000 antigens and 1.5 milligrams of aluminum over 18 years. Today’s complete schedule delivers roughly 165 antigens – which is a 95% reduction – and 5-6 milligrams of aluminum in the same time frame. A single smallpox inoculation in 1900 exposed a child to more antigens than today’s complete series.

A black-and-white photo of a doctor in a white coat giving an injection to a boy who is held by a female nurse.
Jonas Salk, the inventor of the polio vaccine, administers a dose to a boy in 1954.
Underwood Archives via Getty Images

Since 1986, the United States has introduced vaccines against Haemophilus influenzae type b, hepatitis A and B, chickenpox, pneumococcal disease, rotavirus and human papillomavirus. Each addition represents a life-saving advance.

The incidence of Haemophilus influenzae type b, a bacterial infection that can cause pneumonia, meningitis and other severe diseases, has dropped by 99% in infants. Pediatric hepatitis infections are down more than 90%, and chickenpox hospitalizations are down about 90%. The Centers for Disease Control and Prevention estimates that vaccinating children born from 1994 to 2023 will avert 508 million illnesses and 1,129,000 premature deaths.

Placebo testing for vaccines

Kennedy has asserted that only COVID-19 vaccines have undergone rigorous safety trials in which they were tested against placebos. This is categorically wrong.

Of the 378 controlled trials in our database, 195 compared volunteers’ response to a vaccine with their response to a placebo. Of those, 159 gave volunteers only a salt water solution or another inert substance. Another 36 gave them just the adjuvant without any viral or bacterial material, as a way to see whether there were side effects from the antigen itself or the injection. Every routine childhood vaccine antigen appears in at least one such study.

The 1954 Salk polio trial, one of the largest clinical trials in medical history, enrolled more than 600,000 children and tested the vaccine by comparing it with a salt water control. Similar trials, which used a substance that has no biological effect as a control, were used to test Haemophilus influenzae type b, pneumococcal, rotavirus, influenza and HPV vaccines.

Once an effective vaccine exists, ethics boards require new versions be compared against that licensed standard because withholding proven protection from children would be unethical.

How unknown is the safety of widely used vaccines?

Kennedy has insisted on multiple occasions that “nobody has any idea” about vaccine safety profiles. Of the 378 trials in our database, the vast majority published detailed safety outcomes.

Beyond trials, the U.S. operates the Vaccine Adverse Event Reporting System, the Vaccine Safety Datalink and the PRISM network to monitor hundreds of millions of doses for rare problems. The Vaccine Adverse Event Reporting System works like an open mailbox where anyone – patients, parents, clinicians – can report a post-shot problem; the Vaccine Safety Datalink analyzes anonymized electronic health records from large health care systems to spot patterns; and PRISM scans billions of insurance claims in near-real time to confirm or rule out rare safety signals.

These systems led health officials to pull the first rotavirus vaccine in 1999 after it was linked to bowel obstruction, and to restrict the Johnson & Johnson COVID-19 vaccine in 2021 after rare clotting events. Few drug classes undergo such continuous surveillance and are subject to such swift corrective action when genuine risks emerge.

The conflicts of interest claim

On June 9, Kennedy took the unprecedented step of dissolving vetted members of the Advisory Committee on Immunization Practices, the expert body that advises the CDC on national vaccine policy. He has claimed repeatedly that the vast majority of serving members of the committee – 97% – had extensive conflicts of interest because of their entanglements with the pharmaceutical industry. Kennedy bases that number on a 2009 federal audit of conflict-of-interest paperwork, but that report looked at 17 CDC advisory committees, not specifically this vaccine committee. And it found no pervasive wrongdoing – 97% of disclosure forms only contained routine paperwork mistakes, such as information in the wrong box or a missing initial, and not hidden financial ties.

Reuters examined data from Open Payments, a government website that discloses health care providers’ relationships with industry, for all 17 voting members of the committee who were dismissed. Six received no more than US$80 from drugmakers over seven years, and four had no payments at all.

The remaining seven members accepted between $4,000 and $55,000 over seven years, mostly for modest consulting or travel. In other words, just 41% of the committee received anything more than pocket change from drugmakers. Committee members must divest vaccine company stock and recuse themselves from votes involving conflicts.

A term without a meaning

Kennedy has warned that vaccines cause “immune deregulation,” a term that has no basis in immunology. Vaccines train the immune system, and the diseases they prevent are the real threats to immune function.

Measles can wipe immune memory, leaving children vulnerable to other infections for years. COVID-19 can trigger multisystem inflammatory syndrome in children. Chronic hepatitis B can cause immune-mediated organ damage. Preventing these conditions protects people from immune system damage.

Today’s vaccine panel doesn’t just prevent infections; it deters doctor visits and thereby reduces unnecessary prescriptions for “just-in-case” antibiotics. It’s one of the rare places in medicine where physicians like me now do more good with less biological burden than we did 40 years ago.

The evidence is clear and publicly available: Vaccines have dramatically reduced childhood illness, disability and death on a historic scale.The Conversation

Jake Scott, Clinical Associate Professor of Infectious Diseases, Stanford University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post I’m a physician who has looked at hundreds of studies of vaccine safety, and here’s some of what RFK Jr. gets wrong appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Left

This content presents a science-based and fact-checked critique of Robert F. Kennedy Jr.’s statements on vaccines, emphasizing the importance of established public health measures and vaccine safety. It supports mainstream medical consensus and public health institutions like the CDC, while challenging anti-vaccine rhetoric associated with certain political or ideological positions. The tone is objective but leans toward defending regulatory agencies and vaccine advocacy, which aligns more closely with Center-Left perspectives favoring public health expertise and government intervention in health policy.

Continue Reading

The Conversation

Cyberattacks shake voters’ trust in elections, regardless of party

Published

on

theconversation.com – Ryan Shandler, Professor of Cybersecurity and International Relations, Georgia Institute of Technology – 2025-06-27 07:29:00


American democracy faces a crisis of trust, with nearly half of Americans doubting election fairness. This mistrust stems not only from polarization and misinformation but also from unease about the digital infrastructure behind voting. While over 95% of ballots are now counted electronically, this complexity fuels skepticism, especially amid foreign disinformation campaigns that amplify doubts about election security. A study during the 2024 election showed that exposure to cyberattack reports, even unrelated to elections, significantly undermines voter confidence, particularly among those using digital voting machines. To protect democracy, it’s vital to pair secure technology with public education and treat trust as a national asset.

An election worker installs a touchscreen voting machine.
Ethan Miller/Getty Images

Ryan Shandler, Georgia Institute of Technology; Anthony J. DeMattee, Emory University, and Bruce Schneier, Harvard Kennedy School

American democracy runs on trust, and that trust is cracking.

Nearly half of Americans, both Democrats and Republicans, question whether elections are conducted fairly. Some voters accept election results only when their side wins. The problem isn’t just political polarization – it’s a creeping erosion of trust in the machinery of democracy itself.

Commentators blame ideological tribalism, misinformation campaigns and partisan echo chambers for this crisis of trust. But these explanations miss a critical piece of the puzzle: a growing unease with the digital infrastructure that now underpins nearly every aspect of how Americans vote.

The digital transformation of American elections has been swift and sweeping. Just two decades ago, most people voted using mechanical levers or punch cards. Today, over 95% of ballots are counted electronically. Digital systems have replaced poll books, taken over voter identity verification processes and are integrated into registration, counting, auditing and voting systems.

This technological leap has made voting more accessible and efficient, and sometimes more secure. But these new systems are also more complex. And that complexity plays into the hands of those looking to undermine democracy.

In recent years, authoritarian regimes have refined a chillingly effective strategy to chip away at Americans’ faith in democracy by relentlessly sowing doubt about the tools U.S. states use to conduct elections. It’s a sustained campaign to fracture civic faith and make Americans believe that democracy is rigged, especially when their side loses.

This is not cyberwar in the traditional sense. There’s no evidence that anyone has managed to break into voting machines and alter votes. But cyberattacks on election systems don’t need to succeed to have an effect. Even a single failed intrusion, magnified by sensational headlines and political echo chambers, is enough to shake public trust. By feeding into existing anxiety about the complexity and opacity of digital systems, adversaries create fertile ground for disinformation and conspiracy theories.

Just before the 2024 presidential election, Director of the Cybersecurity and Infrastructure Security Agency Jen Easterly explains how foreign influence campaigns erode trust in U.S. elections.

Testing cyber fears

To test this dynamic, we launched a study to uncover precisely how cyberattacks corroded trust in the vote during the 2024 U.S. presidential race. We surveyed more than 3,000 voters before and after election day, testing them using a series of fictional but highly realistic breaking news reports depicting cyberattacks against critical infrastructure. We randomly assigned participants to watch different types of news reports: some depicting cyberattacks on election systems, others on unrelated infrastructure such as the power grid, and a third, neutral control group.

The results, which are under peer review, were both striking and sobering. Mere exposure to reports of cyberattacks undermined trust in the electoral process – regardless of partisanship. Voters who supported the losing candidate experienced the greatest drop in trust, with two-thirds of Democratic voters showing heightened skepticism toward the election results.

But winners too showed diminished confidence. Even though most Republican voters, buoyed by their victory, accepted the overall security of the election, the majority of those who viewed news reports about cyberattacks remained suspicious.

The attacks didn’t even have to be related to the election. Even cyberattacks against critical infrastructure such as utilities had spillover effects. Voters seemed to extrapolate: “If the power grid can be hacked, why should I believe that voting machines are secure?”

Strikingly, voters who used digital machines to cast their ballots were the most rattled. For this group of people, belief in the accuracy of the vote count fell by nearly twice as much as that of voters who cast their ballots by mail and who didn’t use any technology. Their firsthand experience with the sorts of systems being portrayed as vulnerable personalized the threat.

It’s not hard to see why. When you’ve just used a touchscreen to vote, and then you see a news report about a digital system being breached, the leap in logic isn’t far.

Our data suggests that in a digital society, perceptions of trust – and distrust – are fluid, contagious and easily activated. The cyber domain isn’t just about networks and code. It’s also about emotions: fear, vulnerability and uncertainty.

Firewall of trust

Does this mean we should scrap electronic voting machines? Not necessarily.

Every election system, digital or analog, has flaws. And in many respects, today’s high-tech systems have solved the problems of the past with voter-verifiable paper ballots. Modern voting machines reduce human error, increase accessibility and speed up the vote count. No one misses the hanging chads of 2000.

But technology, no matter how advanced, cannot instill legitimacy on its own. It must be paired with something harder to code: public trust. In an environment where foreign adversaries amplify every flaw, cyberattacks can trigger spirals of suspicion. It is no longer enough for elections to be secure − voters must also perceive them to be secure.

That’s why public education surrounding elections is now as vital to election security as firewalls and encrypted networks. It’s vital that voters understand how elections are run, how they’re protected and how failures are caught and corrected. Election officials, civil society groups and researchers can teach how audits work, host open-source verification demonstrations and ensure that high-tech electoral processes are comprehensible to voters.

We believe this is an essential investment in democratic resilience. But it needs to be proactive, not reactive. By the time the doubt takes hold, it’s already too late.

Just as crucially, we are convinced that it’s time to rethink the very nature of cyber threats. People often imagine them in military terms. But that framework misses the true power of these threats. The danger of cyberattacks is not only that they can destroy infrastructure or steal classified secrets, but that they chip away at societal cohesion, sow anxiety and fray citizens’ confidence in democratic institutions. These attacks erode the very idea of truth itself by making people doubt that anything can be trusted.

If trust is the target, then we believe that elected officials should start to treat trust as a national asset: something to be built, renewed and defended. Because in the end, elections aren’t just about votes being counted – they’re about people believing that those votes count.

And in that belief lies the true firewall of democracy.The Conversation

Ryan Shandler, Professor of Cybersecurity and International Relations, Georgia Institute of Technology; Anthony J. DeMattee, Data Scientist and Adjunct Instructor, Emory University, and Bruce Schneier, Adjunct Lecturer in Public Policy, Harvard Kennedy School

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Cyberattacks shake voters’ trust in elections, regardless of party appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This article presents a balanced and fact-focused analysis of trust issues surrounding American elections, emphasizing concerns shared across the political spectrum. It highlights the complexity of digital voting infrastructure and the external threats posed by misinformation and foreign influence without promoting partisan viewpoints. The tone is neutral, grounded in data and research, avoiding ideological framing or advocacy. The piece calls for bipartisan solutions like public education and institutional trust-building, reflecting a centrist perspective that prioritizes democratic resilience over partisan blame.

Continue Reading

The Conversation

Toxic algae blooms are lasting longer than before in Lake Erie − why that’s a worry for people and pets

Published

on

theconversation.com – Gregory J. Dick, Professor of Biology, University of Michigan – 2025-06-26 14:38:00


Federal scientists forecast a mild to moderate harmful algal bloom season in Lake Erie for 2025, though even moderate blooms pose health risks. Harmful algal blooms, mainly caused by excess phosphorus and nitrogen runoff from agriculture, produce toxins harmful to humans, pets, and ecosystems. Recent DNA research revealed new toxins, including microcystins and saxitoxins, raising emerging concerns. Climate change exacerbates blooms by increasing water temperatures and heavy rainfall. Blooms now start earlier and last longer. Reducing nutrient runoff through improved farming practices and wetland restoration, like Ohio’s H2Ohio program, is essential to mitigating future blooms and protecting water quality.

A satellite image from Aug. 13, 2024, shows an algal bloom covering approximately 320 square miles (830 square km) of Lake Erie. By Aug. 22, it had nearly doubled in size.
NASA Earth Observatory

Gregory J. Dick, University of Michigan

Federal scientists released their annual forecast for Lake Erie’s harmful algal blooms on June 26, 2025, and they expect a mild to moderate season. However, anyone who comes in contact with toxic algae can face health risks. And 2014, when toxins from algae blooms contaminated the water supply in Toledo, Ohio, was a moderate year, too.

We asked Gregory J. Dick, who leads the Cooperative Institute for Great Lakes Research, a federally funded center at the University of Michigan that studies harmful algal blooms among other Great Lakes issues, why they’re such a concern.

A bar chart shows 2025's forecast to be more severe than 2023 but less than 2024.
The National Oceanic and Atmospheric Administration’s prediction for harmful algal bloom severity in Lake Erie compared with past years.
NOAA

1. What causes harmful algal blooms?

Harmful algal blooms are dense patches of excessive algae growth that can occur in any type of water body, including ponds, reservoirs, rivers, lakes and oceans. When you see them in freshwater, you’re typically seeing cyanobacteria, also known as blue-green algae.

These photosynthetic bacteria have inhabited our planet for billions of years. In fact, they were responsible for oxygenating Earth’s atmosphere, which enabled plant and animal life as we know it.

An illustration of algae bloom sources shows a farm field, city and large body of water.
The leading source of harmful algal blooms today is nutrient runoff from fertilized farm fields.
Michigan Sea Grant

Algae are natural components of ecosystems, but they cause trouble when they proliferate to high densities, creating what we call blooms.

Harmful algal blooms form scums at the water surface and produce toxins that can harm ecosystems, water quality and human health. They have been reported in all 50 U.S. states, all five Great Lakes and nearly every country around the world. Blue-green algae blooms are becoming more common in inland waters.

The main sources of harmful algal blooms are excess nutrients in the water, typically phosphorus and nitrogen.

Historically, these excess nutrients mainly came from sewage and phosphorus-based detergents used in laundry machines and dishwashers that ended up in waterways. U.S. environmental laws in the early 1970s addressed this by requiring sewage treatment and banning phosphorus detergents, with spectacular success.

How pollution affected Lake Erie in the 1960s, before clean water regulations.

Today, agriculture is the main source of excess nutrients from chemical fertilizer or manure applied to farm fields to grow crops. Rainstorms wash these nutrients into streams and rivers that deliver them to lakes and coastal areas, where they fertilize algal blooms. In the U.S., most of these nutrients come from industrial-scale corn production, which is largely used as animal feed or to produce ethanol for gasoline.

Climate change also exacerbates the problem in two ways. First, cyanobacteria grow faster at higher temperatures. Second, climate-driven increases in precipitation, especially large storms, cause more nutrient runoff that has led to record-setting blooms.

2. What does your team’s DNA testing tell us about Lake Erie’s harmful algal blooms?

Harmful algal blooms contain a mixture of cyanobacterial species that can produce an array of different toxins, many of which are still being discovered.

When my colleagues and I recently sequenced DNA from Lake Erie water, we found new types of microcystins, the notorious toxins that were responsible for contaminating Toledo’s drinking water supply in 2014.

These novel molecules cannot be detected with traditional methods and show some signs of causing toxicity, though further studies are needed to confirm their human health effects.

A young woman and dog walk along a shoreline with blue-green algae in the water.
Blue-green algae blooms in freshwater, like this one near Toledo in 2014, can be harmful to humans, causing gastrointestinal symptoms, headache, fever and skin irritation. They can be lethal for pets.
Ty Wright for The Washington Post via Getty Images

We also found organisms responsible for producing saxitoxin, a potent neurotoxin that is well known for causing paralytic shellfish poisoning on the Pacific Coast of North America and elsewhere.

Saxitoxins have been detected at low concentrations in the Great Lakes for some time, but the recent discovery of hot spots of genes that make the toxin makes them an emerging concern.

Our research suggests warmer water temperatures could boost its production, which raises concerns that saxitoxin will become more prevalent with climate change. However, the controls on toxin production are complex, and more research is needed to test this hypothesis. Federal monitoring programs are essential for tracking and understanding emerging threats.

3. Should people worry about these blooms?

Harmful algal blooms are unsightly and smelly, making them a concern for recreation, property values and businesses. They can disrupt food webs and harm aquatic life, though a recent study suggested that their effects on the Lake Erie food web so far are not substantial.

But the biggest impact is from the toxins these algae produce that are harmful to humans and lethal to pets.

The toxins can cause acute health problems such as gastrointestinal symptoms, headache, fever and skin irritation. Dogs can die from ingesting lake water with harmful algal blooms. Emerging science suggests that long-term exposure to harmful algal blooms, for example over months or years, can cause or exacerbate chronic respiratory, cardiovascular and gastrointestinal problems and may be linked to liver cancers, kidney disease and neurological issues.

A large round structure offshore is surrounded by blue-green algae.
The water intake system for the city of Toledo, Ohio, is surrounded by an algae bloom in 2014. Toxic algae got into the water system, resulting in residents being warned not to touch or drink their tap water for three days.
AP Photo/Haraz N. Ghanbari

In addition to exposure through direct ingestion or skin contact, recent research also indicates that inhaling toxins that get into the air may harm health, raising concerns for coastal residents and boaters, but more research is needed to understand the risks.

The Toledo drinking water crisis of 2014 illustrated the vast potential for algal blooms to cause harm in the Great Lakes. Toxins infiltrated the drinking water system and were detected in processed municipal water, resulting in a three-day “do not drink” advisory. The episode affected residents, hospitals and businesses, and it ultimately cost the city an estimated US$65 million.

4. Blooms seem to be starting earlier in the year and lasting longer – why is that happening?

Warmer waters are extending the duration of the blooms.

In 2025, NOAA detected these toxins in Lake Erie on April 28, earlier than ever before. The 2022 bloom in Lake Erie persisted into November, which is rare if not unprecedented.

Scientific studies of western Lake Erie show that the potential cyanobacterial growth rate has increased by up to 30% and the length of the bloom season has expanded by up to a month from 1995 to 2022, especially in warmer, shallow waters. These results are consistent with our understanding of cyanobacterial physiology: Blooms like it hot – cyanobacteria grow faster at higher temperatures.

5. What can be done to reduce the likelihood of algal blooms in the future?

The best and perhaps only hope of reducing the size and occurrence of harmful algal blooms is to reduce the amount of nutrients reaching the Great Lakes.

In Lake Erie, where nutrients come primarily from agriculture, that means improving agricultural practices and restoring wetlands to reduce the amount of nutrients flowing off of farm fields and into the lake. Early indications suggest that Ohio’s H2Ohio program, which works with farmers to reduce runoff, is making some gains in this regard, but future funding for H2Ohio is uncertain.

In places like Lake Superior, where harmful algal blooms appear to be driven by climate change, the solution likely requires halting and reversing the rapid human-driven increase in greenhouse gases in the atmosphere.The Conversation

Gregory J. Dick, Professor of Biology, University of Michigan

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Toxic algae blooms are lasting longer than before in Lake Erie − why that’s a worry for people and pets appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This article presents a neutral and factual overview of the harmful algal blooms in Lake Erie, relying on scientific data and expert analysis without promoting a political agenda. It references federal and academic research, explains causes like agricultural runoff and climate change, and discusses practical mitigation efforts such as agricultural practice improvements and wetland restoration. The tone is informative and balanced, avoiding partisan framing or ideological language. While it touches on environmental issues that can be politically charged, the article remains focused on evidence-based explanations and policy-neutral recommendations.

Continue Reading

Trending